Unknown

Dataset Information

0

Chemical intervention of the NM23-H2 transcriptional programme on c-MYC via a novel small molecule.


ABSTRACT: c-MYC is an important oncogene that is considered as an effective target for anticancer therapy. Regulation of this gene's transcription is one avenue for c-MYC-targeting drug design. Direct binding to a transcription factor and generating the intervention of a transcriptional programme appears to be an effective way to modulate gene transcription. NM23-H2 is a transcription factor for c-MYC and is proven to be related to the secondary structures in the promoter. Here, we first screened our small-molecule library for NM23-H2 binders and then sifted through the inhibitors that could target and interfere with the interaction process between NM23-H2 and the guanine-rich promoter sequence of c-MYC. As a result, a quinazolone derivative, SYSU-ID-01: , showed a significant interference effect towards NM23-H2 binding to the guanine-rich promoter DNA sequence. Further analyses of the compound-protein interaction and the protein-DNA interaction provided insight into the mode of action for SYSU-ID-01: . Cellular evaluation results showed that SYSU-ID-01: could abrogate NM23-H2 binding to the c-MYC promoter, resulting in downregulation of c-MYC transcription and dramatically suppressed HeLa cell growth. These findings provide a new way of c-MYC transcriptional control through interfering with NM23-H2 binding to guanine-rich promoter sequences by small molecules.

SUBMITTER: Shan C 

PROVIDER: S-EPMC4538829 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chemical intervention of the NM23-H2 transcriptional programme on c-MYC via a novel small molecule.

Shan Chan C   Lin Jing J   Hou Jin-Qiang JQ   Liu Hui-Yun HY   Chen Shuo-Bin SB   Chen Ai-Chun AC   Ou Tian-Miao TM   Tan Jia-Heng JH   Li Ding D   Gu Lian-Quan LQ   Huang Zhi-Shu ZS  

Nucleic acids research 20150627 14


c-MYC is an important oncogene that is considered as an effective target for anticancer therapy. Regulation of this gene's transcription is one avenue for c-MYC-targeting drug design. Direct binding to a transcription factor and generating the intervention of a transcriptional programme appears to be an effective way to modulate gene transcription. NM23-H2 is a transcription factor for c-MYC and is proven to be related to the secondary structures in the promoter. Here, we first screened our smal  ...[more]

Similar Datasets

| S-EPMC4258842 | biostudies-literature
| S-EPMC2615625 | biostudies-literature
| S-EPMC2891668 | biostudies-literature
| S-EPMC6053448 | biostudies-literature
| S-EPMC3317485 | biostudies-literature
| S-ECPF-GEOD-58626 | biostudies-other
| S-EPMC6525070 | biostudies-literature
2024-04-24 | GSE238256 | GEO
2022-09-09 | GSE198280 | GEO
2024-04-24 | GSE238250 | GEO